PHGE: BiomX Inc
PHGE exchange rate has changed by 0.78% for today. During the day, the instrument was traded at a low of 2.56 and at a high of 2.64.
Follow BiomX Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
PHGE News
- BiomX appoints Reuven Yeganeh as director and issues Series Y preferred stock
- All You Need to Know About BiomX (PHGE) Rating Upgrade to Buy
- Crude Oil Falls Over 1%; Structure Therapeutics Shares Jump - Fulcrum Therapeutics (NASDAQ:FULC), Structure Therapeutics (NASDAQ:GPCR)
- US Stocks Mixed; Dow Falls Over 100 Points - Cemtrex (NASDAQ:CETX), Confluent (NASDAQ:CFLT)
- H.C. Wainwright reiterates Buy rating on BiomX stock amid FDA queries
- Why Is BiomX Stock Falling Today? - BiomX (AMEX:PHGE)
- Why Autodesk Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket - Autodesk (NASDAQ:ADSK), Ambarella (NASDAQ:AMBA)
- Upcoming Stock Splits This Week (November 24 to November 28) – Stay Invested - TipRanks.com
- BiomX to implement 1-for-19 reverse stock split on November 25
- BiomX stockholders approve director elections and reverse stock split authorization
- BiomX addresses FDA queries on nebulizer for CF treatment
- BiomX stock faces FDA clinical hold on nebulizer device concerns
- BiomX Inc. (PHGE) Q2 2025 Earnings Call Transcript
- BiomX sets date for 2025 annual meeting and shareholder proposal deadline
- BiomX stock holds Buy rating at H.C. Wainwright as Phase 2b trial begins
- BiomX stock maintains Buy rating at H.C. Wainwright with $15 price target
- BiomX stock soars after initiating Phase 2b trial for cystic fibrosis therapy
- BiomX begins phase 2b trial for phage therapy targeting CF infections
- Biomx stock plunges to 52-week low, hitting $0.47
- BiomX CEO Jonathan Solomon to Present at Biomed Israel 2025 Conference
- H.C. Wainwright cuts BiomX stock target to $15, maintains Buy
Frequently Asked Questions
What is PHGE stock price today?
BiomX Inc stock is priced at 2.59 today. It trades within 2.56 - 2.64, yesterday's close was 2.57, and trading volume reached 29. The live price chart of PHGE shows these updates.
Does BiomX Inc stock pay dividends?
BiomX Inc is currently valued at 2.59. Dividend policy depends on the company, while investors also watch 250.00% and USD. View the chart live to track PHGE movements.
How to buy PHGE stock?
You can buy BiomX Inc shares at the current price of 2.59. Orders are usually placed near 2.59 or 2.89, while 29 and -1.15% show market activity. Follow PHGE updates on the live chart today.
How to invest into PHGE stock?
Investing in BiomX Inc involves considering the yearly range 0.25 - 6.03 and current price 2.59. Many compare 36.32% and 564.10% before placing orders at 2.59 or 2.89. Explore the PHGE price chart live with daily changes.
What are BiomX Inc stock highest prices?
The highest price of BiomX Inc in the past year was 6.03. Within 0.25 - 6.03, the stock fluctuated notably, and comparing with 2.57 helps spot resistance levels. Track BiomX Inc performance using the live chart.
What are BiomX Inc stock lowest prices?
The lowest price of BiomX Inc (PHGE) over the year was 0.25. Comparing it with the current 2.59 and 0.25 - 6.03 shows potential long-term entry points. Watch PHGE moves on the chart live for more details.
When did PHGE stock split?
BiomX Inc has gone through stock splits historically. These changes are visible in , 2.57, and 250.00% after corporate actions.
- Previous Close
- 2.57
- Open
- 2.62
- Bid
- 2.59
- Ask
- 2.89
- Low
- 2.56
- High
- 2.64
- Volume
- 29
- Daily Change
- 0.78%
- Month Change
- 36.32%
- 6 Months Change
- 564.10%
- Year Change
- 250.00%
- Act
- Fcst
- Prev